
-
- Royalty Pharma in its US$827 million acquisition of Ligand Pharmaceuticals’ royalties on sales of Promacta.
- Prosecuting a patent portfolio and providing patent strategy advice for a French pharmaceutical company whose drug product, a combination of three known small molecule drugs, is in Phase 3 clinical trials for a rare genetic disease.
- Drafting, filing, and prosecuting patent applications covering new uses and formulations of legacy in-licensed lead compound as well as new composition of matter applications for drug discovery program on behalf of Cambridge, Massachusetts-based pharmaceutical company.
- Diligence evaluation of a US pharmaceutical company’s patent estate covering a cystic fibrosis small molecule drug candidate in the company’s US$88 million IPO.
- Diligence evaluation of multiple patent estates covering small molecule drug candidates on behalf of a European pharmaceutical company in its US$275 million IPO.
Includes matters handled at Dechert or prior to joining the firm.
- Royalty Pharma in its US$827 million acquisition of Ligand Pharmaceuticals’ royalties on sales of Promacta.
-
- 2020 Pro Bono High Honor Roll, Supreme Judicial Court of Massachusetts (awarded to individual attorneys who complete at least 100 hours of pro bono service during the previous year)
- American Bar Association
- American Intellectual Property Association
- 2020 Pro Bono High Honor Roll, Supreme Judicial Court of Massachusetts (awarded to individual attorneys who complete at least 100 hours of pro bono service during the previous year)
-
joseph.arico@dechert.com
-
+1 617 728 7185
-
+1 617 275 8417
- vCard
Office
Boston
One International Place, 40th Floor, 100 Oliver Street, Boston, MA, United States of America 02110-2605-
+1 617 728 7185
-
+1 617 275 8374
Industries
Education
- University of Notre Dame, B.S., Chemistry, 2004, cum laude
- Boston College, Ph.D., Organic Chemistry, 2010
- Suffolk University Law School, J.D., Intellectual Property Concentration, 2018
Admission
- Massachusetts
- United States Patent and Trademark Office
Languages
- English
- Spanish